DR. ROBERT EDWARD TITCOMB OD
Prescription History 1316954621
Optometrist in Virginia Beach, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ROBERT EDWARD TITCOMB OD, an active Optometrist specialist practicing in Virginia Beach, VA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 684 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 256 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| Latanoprost | 256 | $15.88▼ below VA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 256 Medicare prescriptions for Latanoprost, about 1.8 times the volume of the typical Virginia prescriber of this medication (140). Medicare paid an average of $15.88 per fill, versus $21.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 314.9 30-Day Fills standardized to 30-day supplies 8,528 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 163 | $340.20▼ below VA avg | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 163 Medicare prescriptions for Lumigan, about 2.9 times the volume of the typical Virginia prescriber of this medication (56). Medicare paid an average of $340.20 per fill, versus $478.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 225.3 30-Day Fills standardized to 30-day supplies 6,325 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 104 | $11.80▼ below VA avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 104 Medicare prescriptions for Brimonidine Tartrate, about 1.6 times the volume of the typical Virginia prescriber of this medication (66). Medicare paid an average of $11.80 per fill, versus $42.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 129.2 30-Day Fills standardized to 30-day supplies 3,519 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 89 | $30.29▼ below VA avg | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 89 Medicare prescriptions for Dorzolamide-Timolol, about 1.2 times the volume of the typical Virginia prescriber of this medication (77). Medicare paid an average of $30.29 per fill, versus $35.07 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 165.2 30-Day Fills standardized to 30-day supplies 4,943 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 29 | $237.28▼ below VA avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 29 Medicare prescriptions for Combigan, about 73% of the volume of the typical Virginia prescriber of this medication (40). Medicare paid an average of $237.28 per fill, versus $396.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 30.5 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $158.61▼ below VA avg | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 17 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 74% of the volume of the typical Virginia prescriber of this medication (23). Medicare paid an average of $158.61 per fill, versus $287.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 17.2 30-Day Fills standardized to 30-day supplies 437 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 15 | $214.68▼ below VA avg | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 15 Medicare prescriptions for Alphagan P, about half the volume of the typical Virginia prescriber of this medication (34). Medicare paid an average of $214.68 per fill, versus $419.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 15 30-Day Fills standardized to 30-day supplies 385 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 11 | $41.52▼ below VA avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 11 Medicare prescriptions for Prednisolone Acetate, about 10% of the volume of the typical Virginia prescriber of this medication (115). Medicare paid an average of $41.52 per fill, versus $49.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11.7 30-Day Fills standardized to 30-day supplies 255 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ROBERT EDWARD TITCOMB OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Virginia Beach, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among VA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
